the Clinicaltrail of the Effection Which of Phrenic Block Using in Non-intubated Video-assisted Thoracoscopic Surgery
NCT ID: NCT03653494
Last Updated: 2018-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
80 participants
INTERVENTIONAL
2018-10-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Compare the volume of anesthetic drugs between the two groups.
3. If the date of group S greater than group D,it shows that the effect of anesthetic effect of group D is better than group S.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
2. Compare the volume of anesthetic drugs between the two groups.
3. If the date of group S greater than group D,it shows that the effect of anesthetic effect of group D is better than group S.
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
phrenic block group
non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia、Vagus block and Phrenic block
phrenic block
phrenic block by 1% ropivacaine 5ml
Control group
non-intubated general anesthesia combine with Paravertebral blocks、surface spray anesthesia and Vagus block
no phrenic block
no phrenic block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phrenic block
phrenic block by 1% ropivacaine 5ml
no phrenic block
no phrenic block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No conventional anesthesia contraindication, no history of thoracic surgery, good cardiopulmonary function.
* There is no severe adhesion and calcification in the thoracic cavity, and no artificial pneumothorax is affected.
* the patient has no serious anxiety or depression.
* Small surgical trauma, simple steps, short time.
Exclusion Criteria
* BMI≥26 kg/m2.
* Hemodynamic instability.
* INR≥1.5.
* Respiratory infection, persistent cough or airway mucus hypersecretion, high risk of reflux.
* nervous system disease,such as seizure or brain edema.
* Extensive pleural adhesions or once chest surgery.
* PaO2\<60mmHg or PaCO2\>50 mmHg.
* Central hypopnea syndrome.
* Lung isolation should be used to protect the healthy side of the lung.
* Complicated operation, large trauma, long time, lack of experience or poor cooperation in the surgical team.
* Contraindications to local anesthetic.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenzhen People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dai Z Liang, Doctor
Role: STUDY_CHAIR
Shenzhen People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen People's Hospital
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
daizhongliang-02
Identifier Type: -
Identifier Source: org_study_id